Biotech Active Stocks: Arrowhead Research (NASDAQ:ARWR), Gilead Sciences (NASDAQ:GILD), Novavax (NASDAQ:NVAX), MannKind Corporation (NASDAQ:MNKD)

Arrowhead Research Corp (NASDAQ:ARWR) stock had its “buy” rating reaffirmed by stock analysts at Deutsche Bank in a report issued on Monday, American Banking reports. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was -16.09% in last session and finished the day at $17.37. Traded volume was 7.56million shares in the last session and the average volume of the stock remained 1.44million shares. The beta of the stock remained 2.45. Arrowhead Research Corp (NASDAQ:ARWR) insider ownership is 1.10%.

Gilead Sciences Inc (NASDAQ: GILD ) Sovaldi, for instance, is able to cure some hepatitis C genotypes on its own, but requires help from other drugs for other genotypes. Fortunately, there’s a simple diagnostic to determine the genotype of the virus, making it easy for Gilead to show efficacy. Gilead Sciences, Inc. (NASDAQ:GILD) rose 0.08 percent to $72.13 Monday on volume of 29.29million shares. The intra-day range of the stock was $68.81 to $72.89. Gilead Sciences, Inc. (NASDAQ:GILD) has a market capitalization of $110.95billion.

Novavax Inc (NASDAQ:NVAX) major shareholder Pharmaceuticals Ltd Cadila sold 3,000,000 shares of the stock on the open market in a transaction dated Friday, March 21st. Novavax, Inc. (NASDAQ:NVAX)’s stock on Mar 24, 2014 reported a decrease of -11.75% to the closing price of $4.13. Its fifty two weeks range is $1.68 -$6.95. The total market capitalization recorded $963.40million. The overall volume in the last trading session was 13.73million shares. In its share capital, NVAX has 168.54million outstanding shares.

Shares of MannKind Corporation (NASDAQ:MNKD) were the recipient of some unusual options trading activity on Monday. Traders purchased 21,101 call options on the company, AnalystRatings.NET reports. This is an increase of approximately 105% compared to the average daily volume of 10,311 call options. On Monday, shares of MannKind Corporation (NASDAQ:MNKD) advanced 0.68% to close the day at $5.91. Company monthly performance is recorded as -1.83%. MannKind Corporation (NASDAQ:MNKD) quarterly revenue growth is 19.88%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone